Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 years

  1. Bass, A.D.
  2. Arroyo, R.
  3. Boster, A.L.
  4. Boyko, A.N.
  5. Eichau, S.
  6. Ionete, C.
  7. Limmroth, V.
  8. Navas, C.
  9. Pelletier, D.
  10. Pozzilli, C.
  11. Ravenscroft, J.
  12. Sousa, L.
  13. Tintoré, M.
  14. Uitdehaag, B.M.J.
  15. Baker, D.P.
  16. Daizadeh, N.
  17. Choudhry, Z.
  18. Rog, D.
Zeitschrift:
Multiple Sclerosis and Related Disorders

ISSN: 2211-0356,  2211-0348

Datum der Publikation: 2021

Ausgabe: 49

Art: Artikel

DOI: 10.1016/J.MSARD.2020.102717 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus